과제정보
연구 과제 주관 기관 : National Research Foundation of Korea (NRF), Ministry of Health & Welfare
참고문헌
- Gillis AM. Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes. Circulation 2017;135:593-608. https://doi.org/10.1161/CIRCULATIONAHA.116.025312
- Ko D, Rahman F, Martins MA, et al. Atrial fibrillation in women: treatment. Nat Rev Cardiol 2017;14:113-24. https://doi.org/10.1038/nrcardio.2016.171
- Lip GY, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace 2015;17:24-31. https://doi.org/10.1093/europace/euu155
- Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2005;46:1298-306. https://doi.org/10.1016/j.jacc.2005.05.078
- Shantsila E, Wolff A, Lip GY, Lane DA. Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. Int J Clin Pract 2015;69:840-5. https://doi.org/10.1111/ijcp.12625
- Piccini JP, Simon DN, Steinberg BA, et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry. JAMA Cardiol 2016;1:282-91. https://doi.org/10.1001/jamacardio.2016.0529
- Vallakati A, Reddy M, Sharma A, et al. Impact of gender on outcomes after atrial fibrillation ablation. Int J Cardiol 2015;187:12-6. https://doi.org/10.1016/j.ijcard.2015.03.341
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8. https://doi.org/10.1161/01.STR.22.8.983
- Andersson T, Magnuson A, Bryngelsson IL, et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol 2014;177:91-9. https://doi.org/10.1016/j.ijcard.2014.09.092
- Friberg L, Benson L, Rosenqvist M, Lip GY. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012;344:e3522. https://doi.org/10.1136/bmj.e3522
- Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. https://doi.org/10.1056/NEJMoa0905561
- Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369:2093-104. https://doi.org/10.1056/NEJMoa1310907
- Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92. https://doi.org/10.1056/NEJMoa1107039
- Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91. https://doi.org/10.1056/NEJMoa1009638
- Kim H, Kim TH, Cha MJ, et al. A prospective survey of atrial fibrillation management for real-world guideline adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry. Korean Circ J 2017;47:877-87. https://doi.org/10.4070/kcj.2017.0146
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-76. https://doi.org/10.1016/j.jacc.2014.04.029
- Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100. https://doi.org/10.1378/chest.10-0134
- Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500-10. https://doi.org/10.1093/eurheartj/ehr488
- Tomita H, Okumura K, Inoue H, et al. Validation of risk scoring system excluding female sex from CHA2DS2-VASc in Japanese patients with nonvalvular atrial fibrillation - subanalysis of the J-RHYTHM Registry. Circ J 2015;79:1719-26. https://doi.org/10.1253/circj.CJ-15-0095
- Okumura K, Inoue H, Atarashi H, et al. Validation of CHA(2)DS(2)-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ J 2014;78:1593-9. https://doi.org/10.1253/circj.CJ-14-0144
- Suzuki S, Yamashita T, Okumura K, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 2015;79:432-8. https://doi.org/10.1253/circj.CJ-14-1131
- Lee JM, Kim JB, Uhm JS, Pak HN, Lee MH, Joung B. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA2DS2-VASc scores. Heart Rhythm 2017;14:1297-301. https://doi.org/10.1016/j.hrthm.2017.05.034
- Cooke FL. Women's participation in employment in Asia: a comparative analysis of China, India, Japan and South Korea. Int J Hum Resour Manag 2010;21:2249-70. https://doi.org/10.1080/09585192.2010.509627
- Patterson L, Walcutt B. Korean workplace gender discrimination research analysis: a review of the literature from 1990 to 2010. Asia Pac Bus Rev 2013;19:85-101. https://doi.org/10.1080/13602381.2012.697774
- Hsu JC, Maddox TM, Kennedy K, et al. Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke. J Am Coll Cardiol 2016;67:2913-23. https://doi.org/10.1016/j.jacc.2016.03.581
- Lip GY, Rushton-Smith SK, Goldhaber SZ, et al. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circ Cardiovasc Qual Outcomes 2015;8:S12-20. https://doi.org/10.1161/CIRCOUTCOMES.114.001556
- Perino AC, Fan J, Schmitt SK, et al. Treating specialty and outcomes in newly diagnosed atrial fibrillation: from the TREAT-AF Study. J Am Coll Cardiol 2017;70:78-86. https://doi.org/10.1016/j.jacc.2017.04.054
- Steinberg BA, Shrader P, Thomas L, et al. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J 2017;189:40-7. https://doi.org/10.1016/j.ahj.2017.03.024
- Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Pilote L. Sex Differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2015;8:593-9. https://doi.org/10.1161/CIRCOUTCOMES.114.001398
피인용 문헌
- Sex Difference in Clinical Recurrence After Catheter Ablation in Young Patients With Atrial Fibrillation ― What Is the Underlying Mechanism? ― vol.82, pp.9, 2018, https://doi.org/10.1253/circj.cj-18-0791
- Gender Differences in the Association between Frailty, Cognitive Impairment, and Self-Care Behaviors Among Older Adults with Atrial Fibrillation vol.16, pp.13, 2018, https://doi.org/10.3390/ijerph16132387
- Low Lipid Levels and High Variability are Associated With the Risk of New‐Onset Atrial Fibrillation vol.8, pp.23, 2018, https://doi.org/10.1161/jaha.119.012771
- Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation vol.25, pp.1, 2020, https://doi.org/10.1177/1074248419868996
- Anticoagulant drug utilization pattern and their cost analysis: a retrospective study from Saudi Arabia vol.11, pp.4, 2020, https://doi.org/10.1111/jphs.12382
- Women and atrial fibrillation vol.32, pp.10, 2021, https://doi.org/10.1111/jce.14838